nach oben

Current Hypertension Reports

Erschienen in:

01.07.2015 | Preeclampsia (VD Garovic, Section Editor)

Secondary Hypertension in Pregnancy

verfasst von: Line Malha, Phyllis August

Erschienen in: Current Hypertension Reports | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Hypertension is a common medical complication of pregnancy. Although 75–80 % of women with preexisting essential hypertension will have uncomplicated pregnancies, the presence of secondary forms of hypertension adds considerably to both maternal and fetal morbidity and mortality. Renovascular hypertension, pheochromocytoma, and Cushing’s syndrome in particular are associated with accelerating hypertension, superimposed preeclampsia, preterm delivery, and fetal loss. Primary aldosteronism is a more heterogeneous disorder; there are well-documented cases where blood pressure and hypokalemia are improved during pregnancy due to elevated levels of progesterone. However, superimposed preeclampsia, worsening hypertension, and early delivery are also reported. When possible, secondary forms of hypertension should be diagnosed and treated prior to conception in order to avoid these complications.

1.•

Barton JR, O'Brien JM, Bergauer NK, Jacques DL, Sibai BM. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol. 2001;184(5):979–83. doi:10.1067/mob.2001.112905. A very large observational study reporting the incidence of chronic hypertension in pregnancy over the span of 7 years and its effect on pregnancy outcomes. It also gives differential impact of primary and secondary causes of chronic hypertension.PubMedCrossRef

Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206(2):134 e1–8. doi:10.1016/j.ajog.2011.10.878.CrossRef

Macdonald-Wallis C, Tilling K, Fraser A, Nelson SM, Lawlor DA. Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort. Hypertension. 2014;64(1):36–44. doi:10.1161/hypertensionaha.113.02766.PubMedCentralPubMedCrossRef

Yucesoy G, Ozkan S, Bodur H, Tan T, Caliskan E, Vural B, et al. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet. 2005;273(1):43–9. doi:10.1007/s00404-005-0741-3.PubMedCrossRef

Zugna D, Galassi C, Annesi-Maesano I, Baiz N, Barros H, Basterrechea M, et al. Maternal complications in pregnancy and wheezing in early childhood: a pooled analysis of 14 birth cohorts. Int J Epidemiol. 2015;44(1):199–208. doi:10.1093/ije/dyu260.PubMedCrossRef

6.•

Leffert LR, Clancy CR, Bateman BT, Bryant AS, Kuklina EV. Hypertensive disorders and pregnancy-related stroke: frequency, trends, risk factors, and outcomes. Obstet Gynecol. 2015;125(1):124–31. doi:10.1097/aog.0000000000000590. A very large observational study reporting higher risk for pregnant women with hypertension to have a stroke in the year 2010–2011 as compared to 1994–1995 despite all other advances in the medical field over the past 15 years.PubMedCentralPubMedCrossRef

Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299–306. doi:10.1097/AOG.0b013e3181a45b25.PubMedCrossRef

Ye C, Ruan Y, Zou L, Li G, Li C, Chen Y, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes. PLoS ONE. 2014;9(6):e100180. doi:10.1371/journal.pone.0100180.PubMedCentralPubMedCrossRef

9.••

American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(1122–31):1122–31. doi:10.1097/01.aog.0000437382.03963.88. Guidelines for the treatment of hypertension in pregnancy, they are the main reference for clinicians.

10.

11.

Hussain A, Karovitch A, Carson MP. Blood pressure goals and treatment in pregnant patients with chronic kidney disease. Adv Chronic Kidney Dis. 2015;22(2):165–9. doi:10.1053/j.ackd.2014.08.002.PubMedCrossRef

12.

Dugas G, Fuller J, Singh S, Watson J. Pheochromocytoma and pregnancy: a case report and review of anesthetic management. J Can Anesth. 2004;51(2):134–8. doi:10.1007/bf03018772.CrossRef

13.

Harrington JL, Farley DR, van Heerden JA, Ramin KD. Adrenal tumors and pregnancy. World J Surg. 1999;23(2):182–6.PubMedCrossRef

14.

Biggar MA, Lennard TW. Systematic review of phaeochromocytoma in pregnancy. Br J Surg. 2013;100(2):182–90. doi:10.1002/bjs.8976.PubMedCrossRef

15.

Sarathi V, Lila AR, Bandgar TR, Menon PS, Shah NS. Pheochromocytoma and pregnancy: a rare but dangerous combination. Endocr Pract : Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2010;16(2):300–9. doi:10.4158/ep09191.ra.CrossRef

16.

Oliva R, Angelos P, Kaplan E, Bakris G. Pheochromocytoma in pregnancy: a case series and review. Hypertension. 2010;55(3):600–6. doi:10.1161/hypertensionaha.109.147579.PubMedCrossRef

17.

Harper MA, Murnaghan GA, Kennedy L, Hadden DR, Atkinson AB. Phaeochromocytoma in pregnancy. Five cases and a review of the literature. Br J Obstet Gynaecol. 1989;96(5):594–606.PubMedCrossRef

18.

Ellison GT, Mansberger JA, Mansberger Jr AR. Malignant recurrent pheochromocytoma during pregnancy: case report and review of the literature. Surgery. 1988;103(4):484–9.PubMed

19.

Hudsmith JG, Thomas CE, Browne DA. Undiagnosed phaeochromocytoma mimicking severe preeclampsia in a pregnant woman at term. Int J Obstet Anesth. 2006;15(3):240–5. doi:10.1016/j.ijoa.2005.11.003.PubMedCrossRef

20.

Kudva YC, Sawka AM, Young Jr WF. Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab. 2003;88(10):4533–9. doi:10.1210/jc.2003-030720.PubMedCrossRef

21.

Kamari Y, Sharabi Y, Leiba A, Peleg E, Apter S, Grossman E. Peripartum hypertension from pheochromocytoma: a rare and challenging entity. Am J Hypertens. 2005;18(10):1306–12. doi:10.1016/j.amjhyper.2005.04.021.PubMedCrossRef

22.

Witteles RM, Kaplan EL, Roizen MF. Sensitivity of diagnostic and localization tests for pheochromocytoma in clinical practice. Arch Intern Med. 2000;160(16):2521–4.PubMedCrossRef

23.

Takongmo S, Wawo Yonta E, Gonsu Kamga H, Ngongang J, Simo-Moyo J, Essame Oyono JL, et al. Diagnosis of pheochromocytoma in Yaounde (Cameroon): a study of nine cases. Med Trop (Mars). 2010;70(3):274–6.

24.

Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459–66. doi:10.1056/NEJMoa020152.PubMedCrossRef

25.

Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Surv. 1999;54(11):728–37.PubMedCrossRef

26.

Carty D, Crichton L, Alakandy L, O'Dwyer P, Dominiczak A. Hypertension in pregnancy: think laterally. Eur J Obstet Gynecol Reprod Biol. 2010;150(2):220–1. doi:10.1016/j.ejogrb.2010.03.005.PubMedCrossRef

27.

Wu JC, Wu HS, Lin MS, Chou DA, Huang MH. Comparison of robot-assisted laparoscopic adrenalectomy with traditional laparoscopic adrenalectomy—1 year follow-up. Surg Endosc. 2008;22(2):463–6. doi:10.1007/s00464-007-9488-1.PubMedCrossRef

28.

Brunaud L, Bresler L, Ayav A, Zarnegar R, Raphoz AL, Levan T, et al. Robotic-assisted adrenalectomy: what advantages compared to lateral transperitoneal laparoscopic adrenalectomy? Am J Surg. 2008;195(4):433–8. doi:10.1016/j.amjsurg.2007.04.016.PubMedCrossRef

29.

Kim PT, Kreisman SH, Vaughn R, Panton ON. Laparoscopic adrenalectomy for pheochromocytoma in pregnancy. Can J Surg J Can Chir. 2006;49(1):62–3.

30.

Song Y, Liu J, Li H, Zeng Z, Bian X, Wang S. Outcomes of concurrent Caesarean delivery and pheochromocytoma resection in late pregnancy. Int Med J. 2013;43(5):588–91. doi:10.1111/imj.12118.CrossRef

31.

Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293–300. doi:10.1016/j.jacc.2006.07.059.PubMedCrossRef

32.

Riester A, Fischer E, Degenhart C, Reiser MF, Bidlingmaier M, Beuschlein F, et al. Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism. J Clin Endocrinol Metab. 2014;99(6):E1035–9. doi:10.1210/jc.2013-3789.PubMedCrossRef

33.

Rossi GP, Lenzini L. Primary aldosteronism: molecular mechanisms and diagnosis. 2014.

34.

Westerdahl C, Bergenfelz A, Isaksson A, Nerbrand C, Valdemarsson S. Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area. Scand J Prim Health Care. 2011;29(1):57–62. doi:10.3109/02813432.2011.554015.PubMedCentralPubMed

35.•

Riester A, Reincke M. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur J Endocrinol / Eur Fed Endoc Soc. 2015;172(1):R23–30. doi:10.1530/eje-14-0444. This is a thorough review of the literature and insightful description of the diagnosis and management of primary aldosteronism in pregnancy.CrossRef

36.

Rossi GP. Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue? Curr Hypertens Rep. 2004;6(1):1–4.PubMedCrossRef

37.

Biglieri EG, Slaton Jr PE. Pregnancy and primary aldosteronism. J Clin Endocrinol Metab. 1967;27(11):1628–32. doi:10.1210/jcem-27-11-1628.PubMedCrossRef

38.

Brown MA, Sinosich MJ, Saunders DM, Gallery ED. Potassium regulation and progesterone-aldosterone interrelationships in human pregnancy: a prospective study. Am J Obstet Gynecol. 1986;155(2):349–53.PubMedCrossRef

39.

Okawa T, Asano K, Hashimoto T, Fujimori K, Yanagida K, Sato A. Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature. Am J Perinatol. 2002;19(1):31–6. doi:10.1055/s-2002-20170.PubMedCrossRef

40.

August PJ, A. Roberts J. M. In: Taylor RNR, J.M.; Cunningham, F.G.; Lindheimer, M.D., editor. Chesley’s hypertensive disorders in pregnancy. 4th ed.: Academic Press/Elsevier; 2015.

41.

Podymow T, August P. Hypertension in pregnancy. Adv Chronic Kidney Dis. 2007;14(2):178–90. doi:10.1053/j.ackd.2007.01.008.PubMedCrossRef

42.

Wyckoff JA, Seely EW, Hurwitz S, Anderson BF, Lifton RP, Dluhy RG. Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension. 2000;35(2):668–72.PubMedCrossRef

43.

Kosaka K, Onoda N, Ishikawa T, Iwanaga N, Yamamasu S, Tahara H, et al. Laparoscopic adrenalectomy on a patient with primary aldosteronism during pregnancy. Endocr J. 2006;53(4):461–6.PubMedCrossRef

44.

Hecker A, Hasan SH, Neumann F. Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinol (Copenh). 1980;95(4):540–5.

45.

Caretto A, Primerano L, Novara F, Zuffardi O, Genovese S, Rondinelli M. A therapeutic challenge: Liddle’s syndrome managed with amiloride during pregnancy. Case Rep Obstet Gynecol. 2014;2014:156250. doi:10.1155/2014/156250.PubMedCentralPubMed

46.

Al-Ali NA, El-Sandabesee D, Steel SA, Roland JM. Conn’s syndrome in pregnancy successfully treated with amiloride. J Obstet Gynaecol : J Inst Obstet Gynaecol. 2007;27(7):730–1. doi:10.1080/01443610701667098.CrossRef

47.

Dietz JD, Du S, Bolten CW, Payne MA, Xia C, Blinn JR, et al. A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity. Hypertension. 2008;51(3):742–8. doi:10.1161/hypertensionaha.107.103580.PubMedCrossRef

48.

Baron F, Sprauve ME, Huddleston JF, Fisher AJ. Diagnosis and surgical treatment of primary aldosteronism in pregnancy: a case report. Obstet Gynecol. 1995;86(4 Pt 2):644–5.PubMedCrossRef

49.

Solomon CG, Thiet M, Moore Jr F, Seely EW. Primary hyperaldosteronism in pregnancy. A case report. J Reprod Med. 1996;41(4):255–8.PubMed

50.

Shalhav AL, Landman J, Afane J, Levi R, Clayman RV. Laparoscopic adrenalectomy for primary hyperaldosteronism during pregnancy. J Laparoendosc Adv Surg Tech Part A. 2000;10(3):169–71.CrossRef

51.

Sahota PK, Jain SS, Dhand R. Sleep disorders in pregnancy. Curr Opin Pulm Med. 2003;9(6):477–83.PubMedCrossRef

52.

Pilkington S, Carli F, Dakin MJ, Romney M, De Witt KA, Dore CJ, et al. Increase in Mallampati score during pregnancy. Br J Anaesth. 1995;74(6):638–42.PubMedCrossRef

53.

Antony KM, Agrawal A, Arndt ME, Murphy AM, Alapat PM, Guntupalli KK, et al. Obstructive sleep apnea in pregnancy: reliability of prevalence and prediction estimates. J Perinatol : off J Calif Perinat Assoc. 2014;34(8):587–93. doi:10.1038/jp.2014.48.CrossRef

54.•

O'Brien LM, Bullough AS, Chames MC, Shelgikar AV, Armitage R, Guilleminualt C, et al. Hypertension, snoring, and obstructive sleep apnoea during pregnancy: a cohort study. BJOG : Int J Obstet Gynaecol. 2014;121(13):1685–93. doi:10.1111/1471-0528.12885. This study established the incidence of OSA in pregnancy across different etiology of hypertension and in non-hypertensives. It also recognizes that snoring may be an important symptom and is associated with OSA.CrossRef

55.

Pien GW, Pack AI, Jackson N, Maislin G, Macones GA, Schwab RJ. Risk factors for sleep-disordered breathing in pregnancy. Thorax. 2014;69(4):371–7. doi:10.1136/thoraxjnl-2012-202718.PubMedCrossRef

56.

Reid J, Glew RA, Skomro R, Fenton M, Cotton D, Olatunbosun F, et al. Sleep disordered breathing and gestational hypertension: postpartum follow-up study. Sleep. 2013;36(5):717–21b. doi:10.5665/sleep.2634.PubMedCentralPubMed

57.

Facco FL, Ouyang DW, Zee PC, Grobman WA. Development of a pregnancy-specific screening tool for sleep apnea. J Clin Sleep Med : JCSM : Off Publ Am Acad Sleep Med. 2012;8(4):389–94. doi:10.5664/jcsm.2030.

58.

Louis J, Auckley D, Miladinovic B, Shepherd A, Mencin P, Kumar D, et al. Perinatal outcomes associated with obstructive sleep apnea in obese pregnant women. Obstet Gynecol. 2012;120(5):1085–92. doi:10.1097/AOG.0b013e31826eb9d8.PubMed

59.

Louis JM, Auckley D, Sokol RJ, Mercer BM. Maternal and neonatal morbidities associated with obstructive sleep apnea complicating pregnancy. Am J Obstet Gynecol. 2010;202(3):261 e1–5. doi:10.1016/j.ajog.2009.10.867.CrossRef

60.

Pengo MF, Rossi GP, Steier J. Obstructive sleep apnea, gestational hypertension and preeclampsia: a review of the literature. Curr Opin Pulm Med. 2014;20(6):588–94. doi:10.1097/mcp.0000000000000097.PubMedCrossRef

61.

Reichmann JP. Pregnancy-onset habitual snoring, gestational hypertension, and preeclampsia: prospective cohort study. Am J Obstet Gynecol. 2013;208(6):507. doi:10.1016/j.ajog.2013.01.029.PubMedCrossRef

62.

Chen YH, Kang JH, Lin CC, Wang IT, Keller JJ, Lin HC. Obstructive sleep apnea and the risk of adverse pregnancy outcomes. Am J Obstet Gynecol. 2012;206(2):136 e1–5. doi:10.1016/j.ajog.2011.09.006.CrossRef

63.

Sahin FK, Koken G, Cosar E, Saylan F, Fidan F, Yilmazer M, et al. Obstructive sleep apnea in pregnancy and fetal outcome. Int J Gynaecol Obstet: Off Organ Int Fed Gynaecol Obstet. 2008;100(2):141–6. doi:10.1016/j.ijgo.2007.08.012.CrossRef

64.

Olivarez SA, Maheshwari B, McCarthy M, Zacharias N, van den Veyver I, Casturi L, et al. Prospective trial on obstructive sleep apnea in pregnancy and fetal heart rate monitoring. Am J Obstet Gynecol. 2010;202(6):552 e1–7. doi:10.1016/j.ajog.2009.12.008.CrossRef

65.•

Whitehead C, Tong S, Wilson D, Howard M, Walker SP. Treatment of early-onset preeclampsia with continuous positive airway pressure. Obstet Gynecol. 2015. doi:10.1097/aog.0000000000000508. This article supports the use of CPAP in pregnancy by showing this therapy is effective in women with pre-eclampsia and sleep-disordered breathing.

66.

Blyton DM, Sullivan CE, Edwards N. Reduced nocturnal cardiac output associated with preeclampsia is minimized with the use of nocturnal nasal CPAP. Sleep. 2004;27(1):79–84.PubMed

67.

Edwards N, Blyton DM, Kirjavainen T, Kesby GJ, Sullivan CE. Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia. Am J Respir Crit Care Med. 2000;162(1):252–7. doi:10.1164/ajrccm.162.1.9905006.PubMedCrossRef

68.

Olin JW, Gornik HL, Bacharach JM, Biller J, Fine LJ, Gray BH, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014;129(9):1048–78. doi:10.1161/01.cir.0000442577.96802.8c.PubMedCrossRef

69.

Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182–90. doi:10.1161/circulationaha.112.091223.PubMedCrossRef

70.

Thorsteinsdottir B, Kane GC, Hogan MJ, Watson WJ, Grande JP, Garovic VD. Adverse outcomes of renovascular hypertension during pregnancy. Nat Clin Pract Nephrol. 2006;2(11):651–6. doi:10.1038/ncpneph0310.PubMedCrossRef

71.

Levin A, Linas S, Luft FC, Chapman AB, Textor S. Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension. Am J Nephrol. 2007;27(2):212–20. doi:10.1159/000101000.PubMedCrossRef

72.

Sellars L, Siamopoulos K, Wilkinson R. Prognosis for pregnancy after correction of renovascular hypertension. Nephron. 1985;39(3):280–1.PubMedCrossRef

73.

Hotchkiss RL, Nettles JB, Wells DE. Renovascular hypertension in pregnancy. South Med J. 1971;64(10):1256–8.PubMedCrossRef

74.

Polli N, Pecori Giraldi F, Cavagnini F. Cushing’s disease and pregnancy. Pituitary. 2004;7(4):237–41. doi:10.1007/s11102-005-1479-4.PubMedCrossRef

75.

Guilhaume B, Sanson ML, Billaud L, Bertagna X, Laudat MH, Luton JP. Cushing’s syndrome and pregnancy: aetiologies and prognosis in twenty-two patients. Eur J Med. 1992;1(2):83–9.PubMed

76.

Aron DC, Schnall AM, Sheeler LR. Cushing’s syndrome and pregnancy. Am J Obstet Gynecol. 1990;162(1):244–52.PubMedCrossRef

77.

Lubin V, Gautier JF, Antoine JM, Beressi JP, Vexiau P. Cushing’s syndrome during pregnancy. Presse Med (Paris, France : 1983). 2002;31(36):1706–13.

78.

Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK. Cushing’s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab. 2005;90(5):3077–83. doi:10.1210/jc.2004-2361.PubMedCrossRef

79.

Sheeler LR. Cushing’s syndrome and pregnancy. Endocrinol Metab Clin N Am. 1994;23(3):619–27.

Titel: Secondary Hypertension in Pregnancy
verfasst von: Line Malha
Phyllis August
Publikationsdatum: 01.07.2015
Verlag: Springer US
Erschienen in: Current Hypertension Reports / Ausgabe 7/2015
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI: https://doi.org/10.1007/s11906-015-0563-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2015

Medical Therapies for the Treatment of Pulmonary Arterial Hypertension: How Do We Choose?

Endothelin Receptor Antagonists: New Hope for Renal Protection?

Benefit of Blood Pressure Control in Diabetic Patients

Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders

Antihypertensive Combination Treatment: State of the Art